The Impact of Reimbursement Changes for Intracoronary Stents on Providers and MedicareByPaul T. Vaitkus, MDAugust 1st 1998
Formulary Limitations and the Elderly: Results from the Managed Care Outcomes ProjectBySusan D. Horn, PhD,Phoebe D. Sharkey, PhD,Cheryl Phillips-Harris, MDAugust 1st 1998
The Cost of Inpatient Endometriosis Treatment: An Analysis Based on the Healthcare Cost and Utilization Project Nationwide Inpatient SampleBySean Z. Zhao, MD, PhD,Josephine M. Wong, PharmD,Mary Beth Davis,Gail E. Gersh, PhD,Kenneth E. Johnson, PharmDAugust 1st 1998
Identification and Assessment of High-Risk SeniorsByChad Boult, MD, MPH,Teresa Fama Pualwan, MS,Peter D. Fox, PhD,James T. Pacala, MD,for the HMO Workgroup on Care ManagementAugust 1st 1998
Outpatient Antidepressant Utilization in a Dutch Sick FundByKarl J. Gregor, PharmD,Timothy R. Hylan, PhD,Paul C. M. Van Dijk, MD,Frans Sier,Ralph Quik, MD,Harry Th. Kleintjens, MBA,Tycho Kloppenburg,Christopher H. Young, PhDAugust 1st 1998
Inborn Errors of Metabolism: Medical and Administrative "Orphans"BySusan C. Winter, MD,Neil R. M. Buist, MB, ChBAugust 1st 1998
Treatment Options for Prostate Cancer: Part 2 -- Early and Late Stage and Hormone Refractory DiseaseByLTC Judd W. Moul, MD, MC, USAAugust 1st 1998
Correspondence regarding, "A Cost-Effectiveness Clinical Decision Analysis Model for Schizophrenia"ByPenny Mohr,Peter Neumann,Karl Claxton,Ramy A Mahmoud,Dennis A. Revicki,Cynthia PalmerAugust 1st 1998
The Clinical Value of Commonly Used Spinal Fluid Diagnostic Studies in the Evaluation of Patients with Suspected Multiple SclerosisByGeorge W. Brasher, MD,Alan B. Follender, MD,A. Michael Spiekerman, PhDJuly 31st 1998
